Regulator’s tardiness in approving medicines is hurting the industry and patients
01 July 2019 - 05:03
One of the most frustrating problems that has plagued the SA pharmaceutical landscape for at least the last decade is the inability of the country’s drug regulator to approve medicines timeously.
The regulator can take more than six years to approve a drug that often has already been approved by an advanced-country drug regulator. This tardy process has resulted in a backlog of about 16,000 drugs awaiting marketing approval...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.